Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

WSE:PWX
WSE:PWXChemicals

Discover European Penny Stocks To Watch In January 2026

The European market has recently experienced a downturn, with the pan-European STOXX Europe 600 Index falling by 0.98% amid renewed trade and geopolitical uncertainty. For investors exploring opportunities within this landscape, penny stocks—despite their somewhat outdated moniker—remain a relevant area of interest due to their potential for value and growth. By focusing on companies with solid financials and clear growth prospects, investors can uncover promising opportunities among these...
ENXTPA:ALSTI
ENXTPA:ALSTIMachinery

STIF Société Anonyme And 2 Other Undiscovered European Gems With Strong Potential

In the midst of geopolitical uncertainties and fluctuating economic indicators, European markets have shown resilience, with the pan-European STOXX Europe 600 Index recently experiencing a slight decline amid renewed trade tensions. Despite these challenges, optimism in business outlooks has reached new highs, suggesting potential opportunities for investors seeking to explore lesser-known stocks that might offer robust growth prospects. Identifying promising stocks often involves looking at...
HLSE:ALBAV
HLSE:ALBAVBanks

3 European Dividend Stocks Yielding Over 4.7%

Amid renewed trade and geopolitical uncertainty, European markets have experienced a downturn, with the pan-European STOXX Europe 600 Index ending 0.98% lower. Despite this volatility, dividend stocks remain appealing to investors seeking steady income streams in times of market turbulence. Identifying strong dividend stocks often involves looking for companies with a history of stable earnings and robust cash flow, which can provide resilience during economic fluctuations like those...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Valuation Check After Breakthrough Therapy Status For Sofetabart Mipitecan

The FDA’s Breakthrough Therapy designation for Eli Lilly (LLY) candidate sofetabart mipitecan in platinum resistant ovarian cancer has pushed oncology back into focus for a stock many investors mainly associate with obesity drugs. See our latest analysis for Eli Lilly. The Breakthrough Therapy news lands after a busy start to the year for Eli Lilly, with an AI co-innovation lab launched alongside NVIDIA, new distribution for its obesity medicines through CenterWell Pharmacy, and fresh legal...
NYSE:CMC
NYSE:CMCMetals and Mining

Should Rising Estimates and Bullish Sentiment Around Commercial Metals (CMC) Require Action From Investors?

In recent weeks, Commercial Metals has attracted positive attention as analysts raised earnings estimates, Zacks assigned it a top momentum ranking, and brokerage research generally characterized the shares favorably. Behind the headlines, active participation by hedge funds and insiders, combined with a broadly positive analyst stance, has sharpened focus on how sentiment is evolving around the company. With this backdrop of rising earnings estimates, we will now examine how these...
NasdaqGS:WABC
NasdaqGS:WABCBanks

Weaker Earnings And New Director Appointment Could Be A Game Changer For Westamerica Bancorporation (WABC)

Westamerica Bancorporation recently reported fourth-quarter and full-year 2025 results showing year-over-year declines in net interest income, net income, and earnings per share, while also declaring a quarterly cash dividend of US$0.46 per share payable on February 13, 2026. In addition, the board appointed marketing and business strategy veteran Carter Welch as an independent director effective February 26, 2026, signaling a potential shift in how the bank thinks about growth and client...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

Assessing UFP Technologies (UFPT) Valuation After Recent Share Price Momentum

UFP Technologies (UFPT) has drawn fresh attention after its recent share price move, with the stock closing at US$258.68. Investors are weighing that level against the company’s longer term return profile. See our latest analysis for UFP Technologies. That soft 1 day share price return of 2.99% and 7 day share price return of 0.71% comes after a stronger run, with a 30 day share price return of 9.05% and a 90 day share price return of 29.33%. The 3 year total shareholder return of about 2.4x...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

How Investors May Respond To Mirum Pharmaceuticals (MIRM) 2026 Revenue Guidance Centered On Existing Drugs And Pipeline

In January 2026, Mirum Pharmaceuticals issued earnings guidance for 2026, projecting total product revenue of US$630 million to US$650 million. This outlook highlights the company’s confidence in its existing products and late-stage clinical pipeline as key revenue contributors. Next, we’ll examine how Mirum’s revenue guidance for 2026 shapes the company’s investment narrative and longer-term commercial profile. AI is about to change healthcare. These 109 stocks are working on everything...
NYSE:SYY
NYSE:SYYConsumer Retailing

How Sysco’s Expense Discipline and Volume Momentum At Sysco (SYY) Has Changed Its Investment Story

Sysco Corporation is approaching its fiscal 2026 second-quarter earnings release, with analysts expecting year-over-year gains in both earnings per share and revenue, supported by stronger U.S. Foodservice volumes and contributions from its International segment despite the prior Mexico joint venture divestiture. An interesting element of this setup is management’s emphasis on structural improvements, such as disciplined expense management and volume momentum, as key drivers of anticipated...
NYSE:TPL
NYSE:TPLOil and Gas

A Look At Texas Pacific Land (TPL) Valuation After New Partnership And Insider Buying

Why Texas Pacific Land is back on investors’ radar Texas Pacific Land (TPL) has drawn fresh attention after agreeing to partner with Bolt Data & Energy on large-scale data center campuses and committing a US$50 million investment tied to equity and water supply rights. See our latest analysis for Texas Pacific Land. The recent partnership announcement and insider buying interest have come alongside a 20.66% 1 month share price return and a 16.43% year to date share price return, set against a...
ASX:AFI
ASX:AFICapital Markets

Assessing Australian Foundation Investment’s Valuation After Half Year Profit Decline And New Buyback Program

Why AFIC’s latest earnings, dividend and buyback matter for investors Australian Foundation Investment (ASX:AFI) has just reported its half year result with profit softer than a year earlier, while at the same time confirming a fully franked interim dividend and a special payout to shareholders. The Board has also approved a buyback that covers up to 8.93% of issued capital. This gives investors several moving parts to weigh up around income, capital management and AFIC’s long term investment...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Assessing Hasbro (HAS) Valuation After New Board Appointments Of Doug Bowser And Carla Vernón

Hasbro (HAS) has drawn fresh attention after adding Doug Bowser, former President and COO of Nintendo of America, and Carla Vernón, CEO of The Honest Company, to its Board of Directors. See our latest analysis for Hasbro. The board appointments arrive at a time when short term momentum has been picking up, with a 30-day share price return of 7.41% and a 90-day gain of 13.56%. At the same time, the 1-year total shareholder return of 60.60% and 3-year total shareholder return of 73.50% point to...
NYSE:PNC
NYSE:PNCBanks

Is PNC Financial Services Group (PNC) Offering An Attractive Entry After Recent Share Price Gains

If you are wondering whether PNC Financial Services Group is priced attractively right now, it helps to start by looking past the ticker and into what the current share price might actually reflect. The stock recently closed at US$219.39, with returns of 2.6% over the last 30 days and 14.0% over the past year, while the last 7 days showed a 1.7% decline and the 3 and 5 year returns sit at 51.6% and 83.2% respectively. These moves come as investors continue to reassess large US banks and...